What question did this study set out to answer?

This review aims to examine metabolome changes in Alzheimer’s disease and their associations with pathologies and cognitive traits.

Deciphering the metabolome in Alzheimer’s disease

View Full Paper

Ask AI

Bookmark

Authors

Review explores metabolomics insights in Alzheimer’s disease, highlighting metabolic signatures and their implications.

This review aims to examine metabolome changes in Alzheimer’s disease and their associations with pathologies and cognitive traits.
Analyzed various studies investigating metabolomics in brain and body fluids of Alzheimer’s disease patients.
Summarized metabolic signatures and their correlations with cognitive phenotypes.
Delineated biochemical pathways linked to Alzheimer’s disease pathogenesis.
Identified key metabolites that correlate with Alzheimer’s disease pathologies and cognitive decline.
Unveiled intricate metabolic disturbances associated with Alzheimer’s disease progression.
Provided foundational insights for developing biomarkers and therapeutic strategies targeting metabolic disorders in Alzheimer’s disease.

Yang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark